Table 3.
Individual laboratory relative potency estimates (geometric mean) for CDC assays.
|
Versus IH Refa |
Versus candidate (Sample A) |
|||||||||||
| Candidate (Sample A) |
Sample C |
Coded duplicate (Sample B) |
Sample C |
|||||||||
| Lab |
GM |
%GCV |
n |
GM |
%GCV |
n |
GM |
%GCV |
n |
GM |
%GCV |
n |
| 1 | 1.01 | 10 | 9 | 0.98 | 12 | 8 | 0.99 | 16 | 8 | 0.99 | 17 | 8 |
| 2 | Not available | 1.03 | 11 | 3 | 0.95 | 19 | 3 | |||||
| 3 | 1.00 | 7 | 9 | 0.98 | 8 | 9 | 1.00 | 5 | 9 | 0.98 | 5 | 9 |
| 4 | Not available | 1.03 | 10 | 9 | 0.97 | 7 | 9 | |||||
| 5 | 1.15 | 7 | 9 | 1.12 | 9 | 9 | 0.96 | 7 | 9 | 0.98 | 10 | 9 |
| 6 | 1.01 | n/a | 2 | 1.07 | 7 | 4 | 0.95 | n/a | 2 | 1.02 | 2 | 3 |
| 7 | 1.08 | 12 | 14 | 1.01 | 7 | 8 | 0.99 | 6 | 7 | 0.92 | 13 | 7 |
| 8 | 0.99 | 9 | 8 | 0.93 | 9 | 8 | 0.98 | 9 | 8 | 0.95 | 9 | 7 |
| 9 | 1.26 | 4 | 8 | 1.22 | 8 | 8 | 0.99 | 4 | 9 | 0.96 | 8 | 9 |
| 10 | 1.48 | n/a | 2 | n/a | n/a | 0 | 1.05 | 6 | 5 | 1.16 | n/a | 2 |
| 11 | 1.11 | 12 | 9 | 1.13 | 13 | 8 | 1.02 | 10 | 8 | 1.03 | 10 | 8 |
| 12 | 1.42 | n/a | 2 | 1.47 | n/a | 1 | 1.00 | 5 | 4 | 0.97 | 6 | 3 |
| 13 | 0.96 | 7 | 9 | 0.95 | 4 | 9 | 1.00 | 9 | 9 | 0.99 | 6 | 9 |
| 14 | Not available | 0.98 | 4 | 8 | 0.98 | 6 | 7 | |||||
| 15 | 0.99 | 4 | 9 | 0.99 | 3 | 9 | 1.00 | 3 | 9 | 1.00 | 3 | 9 |
| 16 | 0.95 | 6 | 8 | 0.94 | 7 | 8 | 1.00 | 7 | 7 | 0.99 | 4 | 8 |
a
“In house” reference standard.